Cargando…

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients

The epidermal growth factor system has been associated to prognosis in patients with bladder cancer based mainly on the expression of the epidermal growth factor (EGF) receptor 1 (EGFR) and HER2 and their activating ligands. Since limited information exists concerning the expression of other parts o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Memon, A A, Sorensen, B S, Melgard, P, Fokdal, L, Thykjaer, T, Nexo, E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409781/ https://www.ncbi.nlm.nih.gov/pubmed/15583696 http://dx.doi.org/10.1038/sj.bjc.6602251

Ejemplares similares

The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients
por: Memon, A A, et al.
Publicado: (2006)

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003)

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003)

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
por: Mota, Jose Mauricio, et al.
Publicado: (2017)

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas
por: Hirsch, F R, et al.
Publicado: (2002)

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients
por: Ady, N, et al.
Publicado: (2004)

Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis
por: Chen, I-H, et al.
Publicado: (2003)

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
por: Carlsson, J, et al.
Publicado: (2004)

Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer
por: Sagara, Y, et al.
Publicado: (2004)

Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma
por: Ponnaboina, Divya Madhuri, et al.
Publicado: (2023)

Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer
por: Agerbaek, M, et al.
Publicado: (2003)

Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
por: Buta, Corina, et al.
Publicado: (2016)

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas
por: Aubele, M, et al.
Publicado: (2007)

Clinical significance of transmembrane 4 superfamily in colon cancer
por: Hashida, H, et al.
Publicado: (2003)

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
por: Ebbing, Eva A., et al.
Publicado: (2016)

CXCR4/CXCL12 expression and signalling in kidney cancer
por: Schrader, A J, et al.
Publicado: (2002)

The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer
por: Yonesaka, Kimio, et al.
Publicado: (2015)

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer
por: Kelsey, K T, et al.
Publicado: (2004)

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients
por: Itoi, T, et al.
Publicado: (2004)

Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity
por: Moneef, M A L, et al.
Publicado: (2003)

Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
por: Buta, Corina, et al.
Publicado: (2016)

Review of the Role of HER2/neu in Colorectal Carcinomas
por: Achalla, Lakshmi Sai Vijay, et al.
Publicado: (2022)

Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis
por: Offersen, B V, et al.
Publicado: (2002)

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
por: Hoskin, P J, et al.
Publicado: (2003)

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004)

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
por: Turner, K J, et al.
Publicado: (2002)

Study of Programmed Death Ligand 1 and EGFR/HER2 Expression in Non-Small-Cell Lung Carcinoma With a Clinicopathological Spectrum
por: Laishram, Devina, et al.
Publicado: (2021)

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2002)

MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFβ2
por: Choudhury, A, et al.
Publicado: (2004)

Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation
por: McKeown, S R, et al.
Publicado: (2003)

Ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in oesophageal cancer cells: involvement of the p38MAPK signalling pathway
por: Sutter, A P, et al.
Publicado: (2003)

An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models
por: Xia, Wenle, et al.
Publicado: (2013)

Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma
por: Senff-Ribeiro, A, et al.
Publicado: (2004)

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation via heregulin production and activation of HER3
por: Chakrabarty, Anindita, et al.
Publicado: (2010)

Proliferation and aneusomy predict survival of young patients with astrocytoma grade II
por: Wessels, P H, et al.
Publicado: (2003)

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis
por: Jézéquel, P, et al.
Publicado: (2004)

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
por: Talvensaari-Mattila, A, et al.
Publicado: (2003)

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer
por: Mamot, C, et al.
Publicado: (2003)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies
por: Pedersen, K B, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_hjrdm4o0emeesh8nrcpq0buel5